Doxazosin Tablets recall
FDA recall D-0306-2026 · initiated Jan 21, 2026
Unichem Pharmaceuticals USA Inc. recalled Doxazosin Tablets in Jan 2026 — an FDA Class III recall (D-0306-2026) because Tablets/Capsules Imprinted with Wrong ID.
Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why it was recalled
Tablets/Capsules Imprinted with Wrong ID
Labelling, packaging or a product mix-up
The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 60,000 tablets
Details
- Product
- Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
- Recalling company
- Unichem Labs Ltd
- Classification
- Class III
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide
- Initiated
- Jan 21, 2026
- FDA report date
- Feb 18, 2026
Frequently asked
- Was Doxazosin Tablets recalled?
- Unichem Pharmaceuticals USA Inc. recalled Doxazosin Tablets in Jan 2026 — an FDA Class III recall (D-0306-2026) because Tablets/Capsules Imprinted with Wrong ID. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
- Why was Doxazosin Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0306-2026 was: Tablets/Capsules Imprinted with Wrong ID
- Is a recalled Doxazosin Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Doxazosin Tablets are affected?
- Distributed: Nationwide. The recall covers these lots — Lot # GDSH25006, Exp Date: 08/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0306-2026.